Navigation Links
Novel drug discovery tool could identify promising new therapies for Parkinson's disease
Date:7/13/2009

Researchers funded by the National Institutes of Health have turned simple baker's yeast into a virtual army of medicinal chemists capable of rapidly searching for drugs to treat Parkinson's disease.

In a study published online today in Nature Chemical Biology, the researchers showed that they can rescue yeast cells from toxic levels of a protein implicated in Parkinson's disease by stimulating the cells to make very small proteins called cyclic peptides. Two of the cyclic peptides had a protective effect on the yeast cells and on neurons in an animal model of Parkinson's disease.

"This biological approach to compound development opens up an entirely new direction for drug discovery, not only for Parkinson's disease, but theoretically for any disease where key aspects of the pathology can be reproduced in yeast," says Margaret Sutherland, Ph.D., a program director at NIH's National Institute of Neurological Disorders and Stroke (NINDS). "A key step for the future will be to identify the cellular pathways that are affected by these cyclic peptides."

The research emerged from the lab of Susan Lindquist, Ph.D., a professor of biology at the Massachusetts Institute of Technology (MIT), a member of the Whitehead Institute for Biomedical Research, and a Howard Hughes Medical Institute investigator. Dr. Lindquist is also an investigator at the Massachusetts General Hospital (MGH)/MIT Morris K. Udall Center for Excellence in Parkinson's Research, one of 14 such centers funded by NINDS to develop treatment breakthroughs for Parkinson's disease. The study received additional funding from NIH's National Institute of Environmental Health Sciences, and from the Michael J. Fox Foundation and the American Parkinson's Disease Association.

Parkinson's disease attacks cells in a part of the brain responsible for motor control and coordination. As those neurons degenerate, the disease leads to progressive deterioration of motor functio
'/>"/>

Contact: Daniel Stimson
stimsond@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Page: 1 2 3 4

Related biology technology :

1. Novel method predicts impact of a covert anthrax release
2. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
3. Novel handheld device detects anthrax with outstanding accuracy and reliability
4. Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action
5. Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
6. Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
7. Glenmarks Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
8. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
9. Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
10. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
11. Biomimetic-engineering design can replace spaghetti tangle of nanotubes in novel material

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...gera Therapeutics Inc. announced today the dosing ...y of AEG35156, a targeted antisense therapeutic in...ations. ,, The study, entitled "An Open-Label R...of Apoptosis (XIAP) Antisense AEG35156 Given in Co... in AML Following Failure of a Single Standard Dos...
(Date:11/19/2009)...y latest award for revolutionary hearing aid. , ... 16, 2009 -- Popular Science Magazine has named th...nSound Medical a winner of its coveted Best of Wha...nbsp;  Chosen from thousands of entrants...canal for up to four months while providing natura...
(Date:11/18/2009)...ards and Technology (NIST) has demonstrated a rela...d measuring elusive hazards such as concealed expl...esticides distributed in soil by wind and rain. Th...onal techniques for detecting traces of these mate... distinct electrically positive and negative endsa...
(Date:11/18/2009)... developing new sensors to detect chemical agents ...inst the threat of terrorist attacks. , The devi...dual or crime scene to gather a sample which is th...ct the presence of chemicals within seconds. This ...response to terrorist threats. , The scanning i...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Prototype NIST method detects and measures elusive hazards 2New technology detects chemical weapons in seconds 2
...te Placement of Convertible Preferred Stock -, DA...ulletin Board: ACCP) announced today that it has e... The Company has entered into agreements,with inst...aggregate of,$2.7 million in gross proceeds of the...his equity is in addition to the $9.5 million in g...
...ity data on lead NNRTI, RDEA806, and next generati...scussed -, CARLSBAD, Calif., Jan. 29 Ardea Biosc...preclinical data on the Company,s,non-nucleoside r...ompounds,including RDEA806, RDEA427 and RDEA640, w... on Retroviruses and Opportunistic Infections (CRO...
... Calif., Jan. 29 Edwards Lifesciences,Corporation...heart valves,today announced that it has received ...dministration (FDA) for a revised design to the U....anscatheter aortic heart valve,technology. The FDA...,delivery system to the trial, and also granted pe...
Other Biology Technology:Access Pharmaceuticals Announces $2.7 Million New Equity 2Access Pharmaceuticals Announces $2.7 Million New Equity 3Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 2Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 3Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 2Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 3
(Date:11/20/2009)...coal-tar-based sealcoats in parking lots may be th... a USGS study. PAHs or polycyclic aromatic hydro...d tar deposits, and can have toxic effects. It,s l...dust; however, the specific sources of these PAHs ...ust from indoor areas near parking lots with coal-...
(Date:11/20/2009)... German . , In the current online issue of ...nie Eyerich and Dr. Kilian Eyerich together with t...stituto Dermopatico dell,Immacolata in Rome, prese... milestone on the way to developing new treatment ...riasis and allergic reactions and potentially also...
(Date:11/20/2009)...search Center (ERC) has been awarded a grant from ...hods of recovering and reusing the heat that would...ssion process in a carbon capture system. The goal...apture and sequestration, or storage (CCS), and th...itted into the atmosphere by coal-fired power plan...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 1Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 2Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 3Global Prescription Drugs Market to Cross 24897 Billion by 2015 According to New Report by Global Industry Analysts Inc 12837 1Global Prescription Drugs Market to Cross 24897 Billion by 2015 According to New Report by Global Industry Analysts Inc 12837 2Global Prescription Drugs Market to Cross 24897 Billion by 2015 According to New Report by Global Industry Analysts Inc 12837 3Global Prescription Drugs Market to Cross 24897 Billion by 2015 According to New Report by Global Industry Analysts Inc 12837 4Mission Predisan and Jackson Healthcare 28JH 29 Partner for Medical Missions 50359 1Mission Predisan and Jackson Healthcare 28JH 29 Partner for Medical Missions 50359 2Mission Predisan and Jackson Healthcare 28JH 29 Partner for Medical Missions 50359 3
...consin Biotechnology and Bioengineering Center in ...omising area of protein research more accessible t... set of free tools called ViPDAC (virtual proteomi...on with Amazon,s inexpensive "cloud computing" ser... time on its powerful servers; and free open-sourc...
...f two tiny marine algae, a team of scientists has ...ch in algal physiology, plant biology, and marine ...t the Monterey Bay Aquarium Research Institute (MB...ome analyses involved a collaborative effort betwe...scientists from multiple institutions, including U...
...rts in soil carbon research, farming, and forestry...oresters have to manage soil carbon to reduce gree...kets. Agricultural and forest soils in the U.S. ha...ns of carbon dioxide (CO 2 ) every year, offsettin...he briefing, "Down to Earth Carbon Science: Mitiga...
Other Biology News:Cloud computing brings cost of protein research down to Earth 2Cloud computing brings cost of protein research down to Earth 3Genes from tiny marine algae suggest unsuspected avenues for new research 2Genes from tiny marine algae suggest unsuspected avenues for new research 3Genes from tiny marine algae suggest unsuspected avenues for new research 4Down to Earth carbon science: Briefing April 15 in DC 2
Mouse Anti-Human JRKL Monoclonal Antibody, Unconjugated, Clone 4E10 from Abnova Corporation
...ging system for detection of very low level of lum... extreme sensitive camera to detect low level ligh...us disease research, gene expression, circadian rh... with a motor-driven camera inside the light-tight...
... sets a new standard for high performance flow cyt...strumentation, this easy-to-use benchtop system de... The BD FACSAria instrument is the first benchtop ... flow cell. This new flow cell provides superior ...
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: